ArticleThe Journal of clinical investigation2023

TIGIT inhibition and lenalidomide synergistically promote antimyeloma immune responses after stem cell transplantation in mice.

Simone A Minnie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.